Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Celldex Therapeutics Inc
TCE2Current price
24.2 EUR
-1.2 EUR (-4.72%)
Last closed
25.74 USD
Company
www.celldex.com
ISIN
US15117B2025
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
1 739 544 832 USD
Yield for 12 month
-15.26 %
1Y
3Y
5Y
10Y
15Y
TCE2
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey. Address: Perryville III Building, Hampton, NJ, United States, 08827
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
67.1 USDP/E ratio
–Dividend Yield
–Current Year
+6 883 000 USD
Last Year
+2 357 000 USD
Current Quarter
+3 191 000 USD
Last Quarter
+2 498 000 USD
Current Year
+3 875 000 USD
Last Year
+957 000 USD
Current Quarter
+3 191 000 USD
Last Quarter
+1 701 000 USD
Key Figures TCE2
1 year
3 years
5 years
10 years
EBITDA
-171 060 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-19.73 %
PEG Ratio
–
Return On Equity TTM
-29.84 %
Wall Street Target Price
67.1 USD
Revenue TTM
9 976 000 USD
Book Value
11.85 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
110.3 %
Dividend Yield
–
Gross Profit TTM
-79 901 000 USD
Earnings per share
-2.58 USD
Diluted Eps TTM
-2.58 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TCE2
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TCE2
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
11.02.2019
Dividend Date
11.02.2019
Stock Valuation TCE2
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
98.9007
Price Sales TTM
174.3065
Enterprise Value EBITDA
-17.3415
Price Book MRQ
2.2134
Financials TCE2
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TCE2
For 52 weeks
24.43 USD
53.18 USD
50 Day MA
33.6 USD
Shares Short Prior Month
8 306 171
200 Day MA
37.36 USD
Short Ratio
5.4
Shares Short
8 397 350
Short Percent
14.65 %
BeatStart